Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Aug. 3, 2026 NERV A 12,147 · · 12,147 Direct · Acquired (price as of 2026-10-02)
June 3, 2026 NERV A 50,000 · · 50,000 Direct · Acquired (price as of 2026-10-02)
March 31, 2026 NERV A 12,169 · · 12,169 Direct · Acquired (price as of 2026-10-02)
Dec. 22, 2025 NERV A 364,504 · · 364,504 Direct · Acquired (price as of 2026-10-02)
Nov. 14, 2025 NERV A 9,500 · · 9,500 Direct · Acquired (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Aug. 3, 2026 NERV Stock Option (right to buy) Common Stock (12,147) $3.97 Aug. 2, 2036 12,147 Acquired
June 3, 2026 NERV Stock Option (right to buy) Common Stock (50,000) $4.68 June 2, 2036 50,000 Acquired
March 31, 2026 NERV Stock Option (right to buy) Common Stock (12,169) $6.03 March 30, 2036 12,169 Acquired
Dec. 22, 2025 NERV Stock Option (right to buy) Common Stock (364,504) $3.98 Dec. 21, 2035 364,504 Acquired
Nov. 14, 2025 NERV Stock Option (right to buy) Common Stock (9,500) $4.11 Nov. 13, 2035 9,500 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).